What are Aurinia Pharmaceuticals's profit margins?

Gross margin is 89.7% and operating margin is 41.7%, with a 100.0% net margin.

Where does Aurinia Pharmaceuticals's income statement data come from?

Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Aurinia Pharmaceuticals AUPH Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$77.71M+0.8%	$77.11M+5.0%	$73.47M+4.9%	$70.01M+12.1%	$62.47M+4.3%
Total cost of revenue	$6.51M-26.1%	$8.8M+7.6%	$8.18M+14.9%	$7.12M-17.0%	$8.57M+54.4%
Gross profit	$71.2M+4.2%	$68.32M+4.6%	$65.29M+3.8%	$62.89M+16.7%	$53.89M-0.8%
Gross margin	91.6%+3.0pp	88.6%-0.3pp	88.9%-1.0pp	89.8%+3.6pp	86.3%-4.5pp
Research and development	$7.47M-31.4%	$10.9M+29.2%	$8.44M+13.5%	$7.43M+29.4%	$5.74M-29.2%
General and administrative	$22.03M-24.7%	$29.26M+11.7%	$26.18M+0.6%	$26.02M+27.9%	$20.34M-45.1%
Total costs & expenses	$36.28M-17.3%	$43.88M+0.3%	$43.72M-12.4%	$49.93M+22.9%	$40.62M-34.0%
Operating income	$41.42M+24.6%	$33.24M+11.7%	$29.75M+48.1%	$20.08M-8.1%	$21.85M+1,409%
Operating margin	53.3%+10.2pp	43.1%+2.6pp	40.5%+11.8pp	28.7%-6.3pp	35%+37.8pp
Interest expense	$1.01M-3.3%	$1.05M-4.7%	$1.1M-1.6%	$1.12M+4.7%	$1.07M-6.9%
Income before income taxes	$43.93M+23.1%	$35.69M+11.7%	$31.96M+44.3%	$22.16M-9.0%	$24.35M+1,976%
Income tax expense	$9.57M+105%	-$175.1M-42,704%	$411K-36.1%	$643K-36.0%	$1.01M—
Net income	$34.36M-83.7%	$210.79M+568%	$31.55M+46.7%	$21.51M-7.8%	$23.34M+1,534%
Net margin	44.2%-229pp	273.4%+230pp	42.9%+12.2pp	30.7%-6.6pp	37.4%+35.0pp
Diluted earnings per share	$0.25-83.7%	$1.53+565%	$0.23+43.8%	$0.160.0%	$0.16+1,500%
EBITDA	$46.24M+21.4%	$38.1M+10.1%	$34.61M+38.7%	$24.95M-6.6%	$26.7M+736%
EBITDA margin	59.5%+10.1pp	49.4%+2.3pp	47.1%+11.5pp	35.6%-7.1pp	42.7%+37.4pp
EBIT	$41.42M+24.6%	$33.24M+11.7%	$29.75M+48.1%	$20.08M-8.1%	$21.85M+1,409%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Aurinia Pharmaceuticals's profit margins?: Gross margin is 89.7% and operating margin is 41.7%, with a 100.0% net margin.
Where does Aurinia Pharmaceuticals's income statement data come from?: Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.